Cargando…

Estimating cardiovascular risk in patients with type 2 diabetes: a national multicenter study in Brazil

ABSTRACT: According to Brazilian National Data Survey diabetes is the fifth cause for hospitalization and is one of the ten major causes of mortality in this country. AIMS: to stratify the estimated cardiovascular risk (eCVR) in a population of type 2 diabetics (T2DM) according to the Framingham pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomes, Marilia B, Giannella-Neto, Daniel, Faria, Manuel, Tambascia, Marcos, Fonseca, Reine M, Rea, Rosangela, Macedo, Geisa, Modesto-Filho, João, Schmid, Helena, Bittencourt, Alcina V, Cavalcanti, Saulo, Rassi, Nelson, Pedrosa, Hermelinda, Dib, Sergio A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2775723/
https://www.ncbi.nlm.nih.gov/pubmed/19860912
http://dx.doi.org/10.1186/1758-5996-1-22
_version_ 1782174014815338496
author Gomes, Marilia B
Giannella-Neto, Daniel
Faria, Manuel
Tambascia, Marcos
Fonseca, Reine M
Rea, Rosangela
Macedo, Geisa
Modesto-Filho, João
Schmid, Helena
Bittencourt, Alcina V
Cavalcanti, Saulo
Rassi, Nelson
Pedrosa, Hermelinda
Dib, Sergio A
author_facet Gomes, Marilia B
Giannella-Neto, Daniel
Faria, Manuel
Tambascia, Marcos
Fonseca, Reine M
Rea, Rosangela
Macedo, Geisa
Modesto-Filho, João
Schmid, Helena
Bittencourt, Alcina V
Cavalcanti, Saulo
Rassi, Nelson
Pedrosa, Hermelinda
Dib, Sergio A
author_sort Gomes, Marilia B
collection PubMed
description ABSTRACT: According to Brazilian National Data Survey diabetes is the fifth cause for hospitalization and is one of the ten major causes of mortality in this country. AIMS: to stratify the estimated cardiovascular risk (eCVR) in a population of type 2 diabetics (T2DM) according to the Framingham prediction equations as well as to determine the association between eCVR with metabolic and clinical control of the disease. METHODS: From 2000 to 2001 a cross-sectional multicenter study was conducted in 13 public out-patients diabetes/endocrinology clinics from 8 Brazilian cities. The 10-year risk of developing coronary heart disease (CHD) was estimated by the prediction equations described by Wilson et al (Circulation 1998). LDL equations were preferably used; when patients missed LDL data we used total cholesterol equations instead. RESULTS: Data from 1382 patients (59.0% female) were analyzed. Median and inter-quartile range (IQ) of age and duration of diabetes were 57.4 (51-65) and 8.8 (3-13) years, respectively without differences according to the gender. Forty-two percent of these patients were overweight and 35.4% were obese (the prevalence of higher BMI and obesity in this T2DM group was significantly higher in women than in men; p < 0.001). The overall estimated eCVR in T2DM patients was 21.4 (13.5-31.3). The eCVR was high (> 20%) in 738 (53.4%), intermediate in 202 (14.6%) and low in 442 (32%) patients. Men [25.1(15.4-37.3)] showed a higher eCVR than women [18.8 (12.4-27.9) p < 0.001]. The most common risk factor was high LDL-cholesterol (80.8%), most frequently found in women than in men (p = 0.01). The median of risk factors present was three (2-4) without gender differences. Overall we observed that 60 (4.3%) of our patients had none, 154(11.1%) one, 310 (22.4%) two, 385 (27.9%) three, 300 (21.7%) four, 149 (10.5%) five and six, (2%) six risk factors. A higher eCVR was noted in overweight or obese patients (p = 0.01 for both groups). No association was found between eCVR with age or a specific type of diabetes treatment. A correlation was found between eCVR and duration of diabetes (p < 0.001), BMI (p < 0.001), creatinine (p < 0.001) and triglycerides levels (p < 0.001) but it was not found with HbA1c, fasting blood glucose and post-prandial glucose. A higher eCVR was observed in patients with retinopathy (p < 0.001) and a tendency in patients with microalbuminuria (p = 0.06). Conclusion: our study showed that in this group of Brazilian T2DM the eCVR was correlated with the lipid profile and it was higher in patients with microvascular chronic complications. No correlation was found with glycemic control parameters. These data could explain the failure of intensive glycemic control programs aiming to reduce cardiovascular events observed in some studies.
format Text
id pubmed-2775723
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27757232009-11-11 Estimating cardiovascular risk in patients with type 2 diabetes: a national multicenter study in Brazil Gomes, Marilia B Giannella-Neto, Daniel Faria, Manuel Tambascia, Marcos Fonseca, Reine M Rea, Rosangela Macedo, Geisa Modesto-Filho, João Schmid, Helena Bittencourt, Alcina V Cavalcanti, Saulo Rassi, Nelson Pedrosa, Hermelinda Dib, Sergio A Diabetol Metab Syndr Research ABSTRACT: According to Brazilian National Data Survey diabetes is the fifth cause for hospitalization and is one of the ten major causes of mortality in this country. AIMS: to stratify the estimated cardiovascular risk (eCVR) in a population of type 2 diabetics (T2DM) according to the Framingham prediction equations as well as to determine the association between eCVR with metabolic and clinical control of the disease. METHODS: From 2000 to 2001 a cross-sectional multicenter study was conducted in 13 public out-patients diabetes/endocrinology clinics from 8 Brazilian cities. The 10-year risk of developing coronary heart disease (CHD) was estimated by the prediction equations described by Wilson et al (Circulation 1998). LDL equations were preferably used; when patients missed LDL data we used total cholesterol equations instead. RESULTS: Data from 1382 patients (59.0% female) were analyzed. Median and inter-quartile range (IQ) of age and duration of diabetes were 57.4 (51-65) and 8.8 (3-13) years, respectively without differences according to the gender. Forty-two percent of these patients were overweight and 35.4% were obese (the prevalence of higher BMI and obesity in this T2DM group was significantly higher in women than in men; p < 0.001). The overall estimated eCVR in T2DM patients was 21.4 (13.5-31.3). The eCVR was high (> 20%) in 738 (53.4%), intermediate in 202 (14.6%) and low in 442 (32%) patients. Men [25.1(15.4-37.3)] showed a higher eCVR than women [18.8 (12.4-27.9) p < 0.001]. The most common risk factor was high LDL-cholesterol (80.8%), most frequently found in women than in men (p = 0.01). The median of risk factors present was three (2-4) without gender differences. Overall we observed that 60 (4.3%) of our patients had none, 154(11.1%) one, 310 (22.4%) two, 385 (27.9%) three, 300 (21.7%) four, 149 (10.5%) five and six, (2%) six risk factors. A higher eCVR was noted in overweight or obese patients (p = 0.01 for both groups). No association was found between eCVR with age or a specific type of diabetes treatment. A correlation was found between eCVR and duration of diabetes (p < 0.001), BMI (p < 0.001), creatinine (p < 0.001) and triglycerides levels (p < 0.001) but it was not found with HbA1c, fasting blood glucose and post-prandial glucose. A higher eCVR was observed in patients with retinopathy (p < 0.001) and a tendency in patients with microalbuminuria (p = 0.06). Conclusion: our study showed that in this group of Brazilian T2DM the eCVR was correlated with the lipid profile and it was higher in patients with microvascular chronic complications. No correlation was found with glycemic control parameters. These data could explain the failure of intensive glycemic control programs aiming to reduce cardiovascular events observed in some studies. BioMed Central 2009-10-27 /pmc/articles/PMC2775723/ /pubmed/19860912 http://dx.doi.org/10.1186/1758-5996-1-22 Text en Copyright © 2009 Gomes et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Gomes, Marilia B
Giannella-Neto, Daniel
Faria, Manuel
Tambascia, Marcos
Fonseca, Reine M
Rea, Rosangela
Macedo, Geisa
Modesto-Filho, João
Schmid, Helena
Bittencourt, Alcina V
Cavalcanti, Saulo
Rassi, Nelson
Pedrosa, Hermelinda
Dib, Sergio A
Estimating cardiovascular risk in patients with type 2 diabetes: a national multicenter study in Brazil
title Estimating cardiovascular risk in patients with type 2 diabetes: a national multicenter study in Brazil
title_full Estimating cardiovascular risk in patients with type 2 diabetes: a national multicenter study in Brazil
title_fullStr Estimating cardiovascular risk in patients with type 2 diabetes: a national multicenter study in Brazil
title_full_unstemmed Estimating cardiovascular risk in patients with type 2 diabetes: a national multicenter study in Brazil
title_short Estimating cardiovascular risk in patients with type 2 diabetes: a national multicenter study in Brazil
title_sort estimating cardiovascular risk in patients with type 2 diabetes: a national multicenter study in brazil
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2775723/
https://www.ncbi.nlm.nih.gov/pubmed/19860912
http://dx.doi.org/10.1186/1758-5996-1-22
work_keys_str_mv AT gomesmariliab estimatingcardiovascularriskinpatientswithtype2diabetesanationalmulticenterstudyinbrazil
AT giannellanetodaniel estimatingcardiovascularriskinpatientswithtype2diabetesanationalmulticenterstudyinbrazil
AT fariamanuel estimatingcardiovascularriskinpatientswithtype2diabetesanationalmulticenterstudyinbrazil
AT tambasciamarcos estimatingcardiovascularriskinpatientswithtype2diabetesanationalmulticenterstudyinbrazil
AT fonsecareinem estimatingcardiovascularriskinpatientswithtype2diabetesanationalmulticenterstudyinbrazil
AT rearosangela estimatingcardiovascularriskinpatientswithtype2diabetesanationalmulticenterstudyinbrazil
AT macedogeisa estimatingcardiovascularriskinpatientswithtype2diabetesanationalmulticenterstudyinbrazil
AT modestofilhojoao estimatingcardiovascularriskinpatientswithtype2diabetesanationalmulticenterstudyinbrazil
AT schmidhelena estimatingcardiovascularriskinpatientswithtype2diabetesanationalmulticenterstudyinbrazil
AT bittencourtalcinav estimatingcardiovascularriskinpatientswithtype2diabetesanationalmulticenterstudyinbrazil
AT cavalcantisaulo estimatingcardiovascularriskinpatientswithtype2diabetesanationalmulticenterstudyinbrazil
AT rassinelson estimatingcardiovascularriskinpatientswithtype2diabetesanationalmulticenterstudyinbrazil
AT pedrosahermelinda estimatingcardiovascularriskinpatientswithtype2diabetesanationalmulticenterstudyinbrazil
AT dibsergioa estimatingcardiovascularriskinpatientswithtype2diabetesanationalmulticenterstudyinbrazil